Related Experiment Videos
[Coagulation disorders during orthotopic liver transplantation]
1Second Department of Surgery, Osaka University Medical School, Japan.
Nihon Geka Gakkai Zasshi
|June 1, 1989
Summary
Coagulation disorders after liver transplantation are linked to preserved grafts. Tissue thromboplastin (F-III) released from damaged livers causes these issues, not platelet aggregation or plasminogen activator activity.
Area of Science:
- Hepatology
- Transplantation Immunology
- Hematology
Context:
- Coagulation disorders frequently occur after orthotopic liver transplantation (OLT), particularly post-reperfusion.
- Understanding the specific mechanisms causing these disorders is crucial for improving patient outcomes.
Purpose:
- This study aimed to elucidate the causes of coagulation disorders following liver graft reperfusion.
- Investigate the role of perfusate from fresh versus preserved liver grafts in inducing coagulopathy.
Summary:
- Orthotopic liver transplantation (OLT) was performed on dogs using fresh and preserved liver grafts.
- Coagulation parameters (platelet count, aPTT, PT, fibrinogen) were monitored. Perfusate from preserved grafts induced coagulation disorders in untreated dogs, unlike perfusate from fresh grafts.
- Preserved liver perfusate showed elevated tissue thromboplastin (F-III) activity, while platelet aggregation and plasminogen activator (PA) activity were minimal.
Impact:
- Identifies tissue thromboplastin (F-III) as the primary factor causing post-reperfusion coagulation disorders in liver transplantation.
- Suggests that the degree of liver preservation significantly influences the risk of coagulopathy.
- Provides insights for developing strategies to mitigate coagulation complications in OLT recipients.